American Diabetes Association Scientific Sessions 2026

CagriSema shows strong blood sugar and weight loss results in phase 3 diabetes trials

Novo Nordisk reported significant reductions in HbA1c and body weight with its investigational once-weekly therapy CagriSema across three phase 3…